advisorsecurities master

MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
18761
Ticker
MRVI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-11-20
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MRVI

Detail

Enriched 2026-08-14 20:47

Market cap
$861,159,570.1
Shares outstanding (class)
147,506,164
Shares outstanding (weighted)
148,989,545
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
416
Location
SAN DIEGO, CA
Description

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data